Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193805-13-001602
Filing Date
2013-09-16
Accepted
2013-09-13 19:35:49
Documents
11
Period of Report
2013-06-30

Document Format Files

Seq Description Document Type Size
1 e611297_10q-retrophin.htm 10-Q 696296
2 e611297_ex31-1.htm EX-31.1 14622
3 e611297_ex31-2.htm EX-31.2 14501
4 e611297_ex32-1.htm EX-32.1 5751
5 e611297_ex32-2.htm EX-32.2 5745
  Complete submission text file 0001193805-13-001602.txt   4065779

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rtrx-20130630.xml EX-101.INS 270857
7 XBRL TAXONOMY EXTENSION SCHEMA rtrx-20130630.xsd EX-101.SCH 34524
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rtrx-20130630_cal.xml EX-101.CAL 38355
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rtrx-20130630_def.xml EX-101.DEF 47984
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rtrx-20130630_lab.xml EX-101.LAB 179639
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rtrx-20130630_pre.xml EX-101.PRE 130942
Mailing Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017
Business Address 777 THIRD AVENUE 22ND FLOOR NEW YORK NY 10017 212-983-1310
Retrophin, Inc. (Filer) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: OK | Fiscal Year End: 0229
Type: 10-Q | Act: 34 | File No.: 000-53293 | Film No.: 131097458
SIC: 2834 Pharmaceutical Preparations